Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

28 Apr 2019 - 02 May 2019

ARVO Annual Meeting, Vancouver, BC, Canada

25 Mar 2019 - 27 Mar 2019

BioEurope Spring, Vienna, Austria

16 Mar 2019 - 21 Mar 2019

45th NANOS Annual Meeting, Las Vegas, Nevada, US

10 Jan 2019 - 11 Jan 2019

Oddo BHF Forum, Lyon, France

07 Jan 2019 - 10 Jan 2019

37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

06 Nov 2018 - 08 Nov 2018

World Orphan Drug Congress Europe, Barcelona, Spain

22 Nov 2018 - 23 Nov 2018

Salon Actionaria 2018, Paris, France

23 Oct 2018 - 24 Oct 2018

2nd Annual Gene Therapy for Rare Disorders Europe, London, UK

25 Oct 2018

Ophthalmology Innovation Summit @ AAO, Chicago (IL)

27 Oct 2018 - 30 Oct 2018

American Academy of Ophthalmology, Chicago (IL)

  • View previous 9 articles
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 17
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page